Vion Pharmaceuticals (United States) (Q331764)

company organization in New Haven, United States

Language	Label	Description	Also known as
English	Vion Pharmaceuticals (United States)	company organization in New Haven, United States

Statements

instance of

company

0 references

addresses subject

Epidemiology and Management of Bipolar Disorder

prevalence

132

1 reference

reference URL

https://openalex.org/I867599234

Schizophrenia Research and Treatment

prevalence

132

1 reference

reference URL

https://openalex.org/I867599234

Epilepsy and Seizures

prevalence

128

1 reference

reference URL

https://openalex.org/I867599234

Prenatal Exposure to Antiepileptic Drugs

prevalence

91

1 reference

reference URL

https://openalex.org/I867599234

Developmental Pharmacology in Pediatric Drug Use

prevalence

77

1 reference

reference URL

https://openalex.org/I867599234

Standardisation and Management of COPD

prevalence

58

1 reference

reference URL

https://openalex.org/I867599234

Asthma

prevalence

50

1 reference

reference URL

https://openalex.org/I867599234

Efficacy and Safety of Electroconvulsive Therapy

prevalence

49

1 reference

reference URL

https://openalex.org/I867599234

Attention-Deficit/Hyperactivity Disorder

prevalence

49

1 reference

reference URL

https://openalex.org/I867599234

Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders

prevalence

41

1 reference

reference URL

https://openalex.org/I867599234

Molecular Mechanisms of Depression Treatment Strategies

prevalence

39

1 reference

reference URL

https://openalex.org/I867599234

Pathophysiology of Parkinson's Disease

prevalence

37

1 reference

reference URL

https://openalex.org/I867599234

Health Economics and Quality of Life Assessment

prevalence

34

1 reference

reference URL

https://openalex.org/I867599234

Pulmonary Drug Delivery Techniques

prevalence

33

1 reference

reference URL

https://openalex.org/I867599234

Neuroimmune Interaction in Psychiatric Disorders

prevalence

31

1 reference

reference URL

https://openalex.org/I867599234

Engineering Bacteria for Cancer Treatment

prevalence

31

1 reference

reference URL

https://openalex.org/I867599234

Neurobiological Mechanisms of Drug Addiction and Depression

prevalence

29

1 reference

reference URL

https://openalex.org/I867599234

Deep Brain Stimulation for Neurological Disorders

prevalence

27

1 reference

reference URL

https://openalex.org/I867599234

Acute Myeloid Leukemia

prevalence

23

1 reference

reference URL

https://openalex.org/I867599234

Structure and Function of G Protein-Coupled Receptors

prevalence

23

1 reference

reference URL

https://openalex.org/I867599234

Computational Methods in Drug Discovery

prevalence

22

1 reference

reference URL

https://openalex.org/I867599234

Drug Metabolism and Pharmacogenomics

prevalence

21

1 reference

reference URL

https://openalex.org/I867599234

Mechanical Ventilation in Respiratory Failure and ARDS

prevalence

20

1 reference

reference URL

https://openalex.org/I867599234

Emotion Regulation and Psychopathology in Children and Adolescents

prevalence

20

1 reference

reference URL

https://openalex.org/I867599234

DNA Topoisomerases: Structure, Function, and Inhibition

prevalence

18

1 reference

reference URL

https://openalex.org/I867599234

coordinate location

41°9'19"N, 111°56'20"W

1 reference

reference URL

https://openalex.org/I867599234

country

United States of America

1 reference

reference URL

https://openalex.org/I867599234

official website

http://www.vion.com/

1 reference

reference URL

https://openalex.org/I867599234

OpenAlex ID

I867599234

0 references

Research Organization Registry ID

036dfq243

0 references

Anonymous

Search

Vion Pharmaceuticals (United States) (Q331764)

Namespaces

More

Page actions

Statements

Navigation

Navigation

Wikibase

Wiki tools

Wiki tools

Anonymous

Search

Vion Pharmaceuticals (United States) (Q331764)

Statements

Navigation

Wiki tools

Page tools

Other projects